You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
九典制藥(300705.SZ):整體而言,化學藥貼膏劑增速比中成藥貼膏劑增長速度快
格隆匯 10-12 14:46

格隆匯10月12日丨九典制藥(300705.SZ)在投資者關係活動上表示,根據米內網的數據顯示,外用貼膏劑2023年的市場銷售規模約203.64億元,2022年的市場銷售規模約184億,整體增長率在10%左右,其中中成藥貼膏劑2023年佔比為66.06%,2022年佔比為67.97%;化學藥貼膏劑2023年佔比為33.94%,2022年佔比為32.03%。化學藥貼膏劑的佔比在穩步上升,在醫院端化學藥貼膏劑的近三年的複合增長率約為9.67%,中成藥貼膏劑的近三年的複合增長率約為0.56%;零售端化學藥貼膏劑的近三年的複合增長率約為2.02%,中成藥貼膏劑的近三年的複合增長率約為1.57%。整體而言,化學藥貼膏劑增速比中成藥貼膏劑增長速度快,醫院端增速比零售端增速快。未來化學藥貼膏劑還有很大的增長空間。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account